Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 13, 2026

Total Value ($000): $1,547,067 (100.0% shares, 0.0% debt)

Holdings (47)

Decreased Positions (9)

Unchanged Positions (27)

SABS SAB Biotherapeutics Inc 2.8%
Value ($000) $42,711 Shares 11,420,000 Est. Cost $2.26 Unrealized +45.5%
DYN Dyne Therapeutics Inc 3.3%
Value ($000) $51,149 Shares 2,614,960 Est. Cost $14.50 Unrealized +30.6%
ABVX Abivax SA - ADR 3.1%
Value ($000) $48,454 Shares 359,305 Est. Cost $84.90 Unrealized
CMPX Compass Therapeutics Inc 3.3%
Value ($000) $51,259 Shares 9,545,466 Est. Cost $3.04 Unrealized +52.1%
TRVI Trevi Therapeutics Inc 4.1%
Value ($000) $63,785 Shares 5,094,668 Est. Cost $4.23 Unrealized +173.0%
Avadel Pharmaceuticals PLC 3.7%
Value ($000) $57,843 Shares 2,684,109 Est. Cost $13.12 Unrealized
ERAS Erasca Inc 2.2%
Value ($000) $34,497 Shares 9,273,428 Est. Cost $2.00 Unrealized +40.3%
ACRS Aclaris Therapeutics, Inc. 1.7%
Value ($000) $26,756 Shares 8,888,888 Est. Cost $2.49 Unrealized +1.6%
VRDN Viridian Therapeutics Inc 2.0%
Value ($000) $30,578 Shares 982,576 Est. Cost $15.47 Unrealized +77.3%
DRUG Bright Minds Biosciences Inc 2.5%
Value ($000) $39,146 Shares 501,617 Est. Cost $37.00 Unrealized +80.6%
LBRX LB Pharmaceuticals Inc 1.2%
Value ($000) $17,808 Shares 800,000 Est. Cost $15.87 Unrealized +10.1%
PEPG Pepgen Inc 1.0%
Value ($000) $15,136 Shares 2,325,000 Est. Cost $1.61 Unrealized +222.0%
CTMX Cytomx Therapeutics Inc 0.8%
Value ($000) $12,288 Shares 2,884,615 Est. Cost $1.61 Unrealized +135.7%
SRZN Surrozen Inc 0.4%
Value ($000) $5,876 Shares 260,000 Est. Cost $11.62 Unrealized +39.2%
UNCY Unicycive Therapeutics 0.7%
Value ($000) $10,328 Shares 1,789,916 Est. Cost $5.52 Unrealized -3.2%
EPRX Eupraxia Pharmaceuticals Inc 0.7%
Value ($000) $10,193 Shares 1,350,000 Est. Cost $5.44 Unrealized +13.3%
TIL Instil Bio Inc 0.2%
Value ($000) $3,220 Shares 292,743 Est. Cost $7.23 Unrealized +104.5%
MNPR Monopar Therapeutics Inc 0.4%
Value ($000) $5,910 Shares 90,500 Est. Cost $44.70 Unrealized +82.8%
GERN Geron Corp 2.3%
Value ($000) $35,937 Shares 27,225,292 Est. Cost $1.62 Unrealized -22.4%
SLN Silence Therapeutics PLC 0.4%
Value ($000) $6,721 Shares 1,105,454 Est. Cost $19.65 Unrealized
TENX Tenax Therapeutics Inc 0.2%
Value ($000) $2,540 Shares 208,333 Est. Cost $3.62 Unrealized +140.2%
CRVS Corvus Pharmaceuticals Holdings 1.1%
Value ($000) $17,206 Shares 2,234,566 Est. Cost $4.87 Unrealized +62.0%
DNTH Dianthus Therapeutics Inc 0.9%
Value ($000) $14,588 Shares 353,998 Est. Cost $25.56 Unrealized +51.7%
SERA Sera Prognostics Inc 0.3%
Value ($000) $4,869 Shares 1,650,440 Est. Cost $10.38 Unrealized -68.9%
ABEO Abeona Therapeutics, Inc. 0.6%
Value ($000) $9,711 Shares 1,842,751 Est. Cost $5.10 Unrealized -1.3%
DTIL Precision Biosciences Inc 0.0%
Value ($000) $19 Shares 4,675 Est. Cost $12.24 Unrealized -53.6%
SVA Sinovac Biotech Ltd. 2.5%
Value ($000) $38,192 Shares 5,903,000 Est. Cost $6.47 Unrealized 0.0%